Holen Sie sich die Stockscreener-App
1.99
1.00%
-0.02
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
18.13%
0.6606
|
0.8069 | 0.7663 | 1.027 | 0.5899 |
| Operating Expenses |
24.69%
1.6323
|
1.309 | 1.3893 | 1.5717 | 1.3143 |
| Operating Income/Loss |
93.52%
-0.9717
|
-0.5021 | -0.623 | -0.5447 | -0.7244 |
| Nonoperating Income/Loss |
8.18%
0.042
|
0.0457 | 0.044 | 0.0348 | 0.0357 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
103.71%
-0.9297
|
-0.4564 | -0.5791 | -0.5099 | -0.6887 |
| Basic Average Shares |
0.14%
2.2944
|
2.2911 | - | 1.5421 | 1.5421 |
| Diluted Average Shares |
0.14%
2.2944
|
2.2911 | - | 1.5421 | 1.5421 |
| Basic Earnings Per Share |
105.00%
-0.41
|
-0.20 | - | -0.33 | -0.45 |
| Diluted Earnings Per Share |
105.00%
-0.41
|
-0.20 | - | -0.33 | -0.45 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):